Research interests include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, CAR-T cell therapy research, and Chronic Myeloid Leukemia Treatments.
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology2024cited by 78position: middledoi
Phase 1b Study of Menin-KMT2A Inhibitor Bleximenib in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia with <i>KMT2Ar</i> or <i>NPM1</i> Alterations